Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$67.0 - $84.39 $2.66 Million - $3.35 Million
-39,679 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$55.23 - $79.93 $2.19 Million - $3.17 Million
39,679 New
39,679 $3.08 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Blue Rock Advisors, LLC Portfolio

Follow Blue Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Rock Advisors, LLC with notifications on news.